Rachelle Suzanne Jacques - 30 May 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Reporting relationship: Director
Issuer ticker: CRBP
Reported as of: 30 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2024, 16:29:27 UTC
Prior SEC filing: 20 May 2024
Next SEC filing: 17 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Meghan Houghton, attorney-in-fact for Rachelle Jacques

Key filing fact

Rachelle Suzanne Jacques filed Form 4 for Corbus Pharmaceuticals Holdings, Inc. (CRBP) on 03 Jun 2024.

Key facts

This page summarizes Rachelle Suzanne Jacques's Form 4 filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2024, 16:29.

Change

Previous filing in this sequence was filed on 20 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRBP transaction

Common Stock, par value $0.0001 per share

Award

Transaction value: $0
Shares: +2,783
Change %
Price: $0.000000
Shares after: 2,783
Date: 30 May 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On May 30, 2024, 2,783 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.